NCT00065650已完成2 期
Pilot Study of Vedic Medicine for Type 2 Diabetes
National Center for Complementary and Integrative Health (NCCIH)1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2003年7月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- HbA1C
研究概览
简要总结
The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.
详细描述
Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Kaiser Permanente members
- •Newly diagnosed type 2 Diabetes
- •Baseline glycosylated hemoglobin level of 6.0-7.9.
排除标准
- •Pregnancy or nursing mother
- •Currently taking warfarin
- •Diagnosis of psychotic disorder or recent hospitalization for depression
- •Unable to comply with or attend treatment sessions
结局指标
主要结局
HbA1C
时间窗: 3 months
次要结局
- Lipids(3 and 6 months)
- Fasting Glucose(3 and 6 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A Study of LY2409021 in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2NCT01241448Eli Lilly and Company263
已完成
不适用
COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation TherapyEndocrine, Nutritional and Metabolic Diseases (E00-E89)DiabetesNCT02278068Metavention46
尚未招募
不适用
Effect of Phalatrikadi Kwatha and Triphaladi Kwatha in the management of MadhumehaCTRI/2019/06/019788Government Akhandanand Ayurved College Bhadra Ahmedabad
已完成
2 期
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)Diabetic NephropathiesNCT01968668Bayer96
招募中
4 期
Fingolimod for Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT05307731General Hospital of Shenyang Military Region40